Table 1 Demographic and comorbid of study subjects according to length of hospitalization (LOHS)
From: Bayesian model averaging for predicting factors associated with length of COVID-19 hospitalization
Characteristic | LOHS(day) | X 2 | p- value | |
|---|---|---|---|---|
 > 5 |  ≤ 5 |  |  | |
Sex | ||||
 Male | 1152(42.2) | 1580 (57.8) |  |  |
 Female | 1049(46.3) | 1215(53.7) | 8.7 | 0.003 |
Age group | ||||
 ≤50 | 646(34.8) | 1209(65.2) |  |  |
 51–64 | 683(46.8) | 775(53.2) |  |  |
 ≥65 | 872(51.8) | 811(48.2) | 109.8 | 0.001 |
Diabetes | ||||
 No | 1599(41.1) | 2290(58.9) |  |  |
 Yes | 602(54.4) | 505(45.6) | 61.5 | 0.001 |
Immunodeficiency | ||||
 No | 2188(44) | 2787(56) |  |  |
 Yes | 13 (61.9) | 8(38.1) | 2.7 | 0.099 |
Asthma | ||||
 No | 2155(43.9) | 2750(56.1) |  |  |
 Yes | 46(50.5) | 45(49.5) | 1.5 | 0.208 |
COPD | ||||
 No | 2179(43.9) | 2783(56.1) |  |  |
 Yes | 22 (64.7) | 12(35.3) | 5.9 | 0.015 |
Chronic Nervous Disorders | ||||
 No | 2172(43.9) | 2775(56.1) |  |  |
 Yes | 29(59.2) | 20(40.8) | 4.5 | 0.032 |
HTN | ||||
 No | 1612(41.5) | 2275(58.5) |  |  |
 Yes | 589(53.1) | 520(46.9) | 47.4 | 0.001 |
Other Chronic Disorders | ||||
 No | 1882(43.4) | 2451(56.6) |  |  |
 Yes | 319(48.1) | 344 (51.9) | 5.1 | 0.024 |